Biotechnological Ricin for Immunological Studies from China
Recombinant ricin toxin produced through biotech processes for studying immune responses and antibody production. Classified in HTS 3002.49.0010 as a modified toxin for diagnostic and therapeutic research. Used in labs to develop countermeasures against bioterrorism agents.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include biotech origin certificate and sequence data to justify classification under modified immunological products
• Use IATA-compliant packaging for air import; verify receiver's BSL-3 lab status to prevent denial